These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32097471)

  • 1. Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.
    Gwinnutt JM; Leggett S; Lunt M; Barton A; Hyrich KL; Walker-Bone K; Verstappen SMM;
    Rheumatology (Oxford); 2020 Oct; 59(10):2908-2919. PubMed ID: 32097471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.
    Emery P; Smolen JS; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Kavanaugh A
    Rheumatology (Oxford); 2016 Aug; 55(8):1458-65. PubMed ID: 27114561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients.
    Druce KL; Aikman L; Dilleen M; Burden A; Szczypa P; Basu N
    Arthritis Res Ther; 2018 May; 20(1):96. PubMed ID: 29843776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.
    Verstappen SM
    Best Pract Res Clin Rheumatol; 2015 Jun; 29(3):495-511. PubMed ID: 26612244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study.
    van Vollenhoven RF; Cifaldi MA; Ray S; Chen N; Weisman MH
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):226-34. PubMed ID: 20191522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study.
    Anis A; Zhang W; Emery P; Sun H; Singh A; Freundlich B; Sato R
    Rheumatology (Oxford); 2009 Oct; 48(10):1283-9. PubMed ID: 19690125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?
    Nadin T; Wallis D; Holroyd CR; D'Angelo S; Walker-Bone K; Edwards CJ
    BMC Musculoskelet Disord; 2020 Apr; 21(1):209. PubMed ID: 32252744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).
    Sergeant JC; Hyrich KL; Anderson J; Kopec-Harding K; Hope HF; Symmons DPM; ; Barton A; Verstappen SMM
    Arthritis Res Ther; 2018 Jul; 20(1):147. PubMed ID: 30005689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis.
    George MD; Sauer BC; Teng CC; Cannon GW; England BR; Kerr GS; Mikuls TR; Baker JF
    J Rheumatol; 2019 Apr; 46(4):343-350. PubMed ID: 30275262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review.
    ter Wee MM; Lems WF; Usan H; Gulpen A; Boonen A
    Ann Rheum Dis; 2012 Feb; 71(2):161-71. PubMed ID: 21998122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Work participation is reduced during the development of RA, months before clinical arthritis manifests.
    Rogier C; de Jong PHP; van der Helm-van Mil AHM; van Mulligen E
    Rheumatology (Oxford); 2022 May; 61(6):2583-2589. PubMed ID: 34698809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.
    Behrens F; Tony HP; Koehm M; Schwaneck EC; Gnann H; Greger G; Burkhardt H; Schmalzing M
    Clin Rheumatol; 2020 Sep; 39(9):2583-2592. PubMed ID: 32206973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
    Hirata A; Suenaga Y; Miyamura T; Matsui T; Tohma S; Suematsu E; Ohnaka K; Takayanagi R
    Int J Rheum Dis; 2018 Apr; 21(4):828-835. PubMed ID: 27126059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.
    Gossec L; Humphries B; Rutherford M; Taieb V; Willems D; Tillett W
    Arthritis Res Ther; 2024 Feb; 26(1):50. PubMed ID: 38360699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J; De Bandt M; Lukas C; Morel J; Combe B
    J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
    Kobayakawa T; Kojima T; Takahashi N; Hayashi M; Yabe Y; Kaneko A; Shioura T; Saito K; Hirano Y; Kanayama Y; Miyake H; Asai N; Funahashi K; Hirabara S; Hanabayashi M; Asai S; Ishiguro N
    Mod Rheumatol; 2015 Mar; 25(2):251-6. PubMed ID: 25211402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M;
    Ann Rheum Dis; 2017 Jul; 76(7):1245-1252. PubMed ID: 28073801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of studies of productivity loss due to rheumatoid arthritis.
    Burton W; Morrison A; Maclean R; Ruderman E
    Occup Med (Lond); 2006 Jan; 56(1):18-27. PubMed ID: 16286432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
    Kihara M; Davies R; Kearsley-Fleet L; Watson KD; Lunt M; Symmons DP; Hyrich KL;
    Clin Rheumatol; 2017 Feb; 36(2):241-250. PubMed ID: 27913894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.